| CTRI Number |
CTRI/2025/09/094688 [Registered on: 12/09/2025] Trial Registered Prospectively |
| Last Modified On: |
11/09/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Ayurveda |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
How Night Shifts Affect Digestion: An Ayurvedic Study on Body Clock Imbalance and Natural Treatments for Amlapitta |
|
Scientific Title of Study
|
A Cross-Sectional Observational Study of Association between Circadian Rhythm Alteration and Doshic Imbalance in Night Workers having Amlapitta and A Clinical Comparative Study to Evaluate the Effect of Yavadi Kwatha and Amlapitta Mishran in Amlapitta |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Suryawanshi Payal Prataprao |
| Designation |
PhD SCHOLAR |
| Affiliation |
National Institute of Ayurveda |
| Address |
Department of Roga Nidana Evam Vikriti Vigyana, OPD no 06 and 17, National Institute Of Ayurveda Deemed To Be University, Jorawar Singh Gate, Amer Road
Jaipur RAJASTHAN 302002 India |
| Phone |
7387993301 |
| Fax |
|
| Email |
payalps234@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Balkrishan Sevatkar |
| Designation |
Professor |
| Affiliation |
National Institute of Ayurveda |
| Address |
Department of Roga Nidana Evam Vikriti Vigyana, OPD no 06 and 17, National Institute Of Ayurveda Deemed To Be University, Jorawar Singh Gate, Amer Road
Jaipur RAJASTHAN 302002 India |
| Phone |
9352311105 |
| Fax |
|
| Email |
drbks6@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Suryawanshi Payal Prataprao |
| Designation |
PhD SCHOLAR |
| Affiliation |
National Institute of Ayurveda |
| Address |
Department of Roga Nidana Evam Vikriti Vigyana, OPD no 06 and 17, National Institute Of Ayurveda Deemed To Be University, Jorawar Singh Gate, Amer Road
RAJASTHAN 302002 India |
| Phone |
7387993301 |
| Fax |
|
| Email |
payalps234@gmail.com |
|
|
Source of Monetary or Material Support
|
| National Institute Of Ayurveda Deemed To Be University, Jorawar Singh Gate, Amer Road 302002, Jaipur, Rajasthan, Inida |
|
|
Primary Sponsor
|
| Name |
National Institute of Ayurveda |
| Address |
Jorawar Singh Gate, Amer Road, 302002, Jaipur, Rajasthan |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| SURYAWANSHI PAYAL PRATAPRAO |
National Institute of Ayurveda |
OPD no 17 and Opd 6, Department of Roga Nidana Evam Vikriti Vigyana, Jorawar Singh Gate, Amer Road, 302002 Jaipur RAJASTHAN |
07387993301
payalps234@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| INSTITUTIONAL ETHICS COMMITTEE NATIONAL INSTITUTE OF AYURVEDA |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:K297||Gastritis, unspecified. Ayurveda Condition: AMLAPITTAM, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Comparator Arm | Drug | Other than Classical | | (1) Medicine Name: Amlapitta Mishran, Reference: NA, Route: Oral, Dosage Form: Sharkara/ Syrup, Dose: 15(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: - | | 2 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Yavadi Kwath, Reference: Mishra S.N. Bhaisajya Ratnavali of Sen Govind D. 1st edition. Varanasi; Chaukhamba Surbharti Prakashan; 2012. Adhyaya 56, Amlapittarogadhikar 901p, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: - |
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Night workers of either sex
Presence of Amlapitta as diagnosed by Amlapitta Symptom Rating Scale Score of 5 or more
Participants willing to give written informed consent.
Currently engaged in night shift work (Ratrojagaran will be considered 12 pm to 6am minimum of 3 months, more than 5 nights/month)
|
|
| ExclusionCriteria |
| Details |
Pregnant or lactating women.
Participants with documented H pylori infection.
Participants with history of psychiatric disorders including eating disorders.
Participants documented with chronic degenerative diseases including uncontrolled hepatic, renal or endocrine diseases (except diabetes controlled by oral hypoglycaemic agents or controlled hypothyroidism) malabsorption or chronic diarrhoea, history of seizures or epilepsy, gastric surgery or participants with oncological diseases.
Participants with history of gastroesophageal surgery and surgery to reduce the secretion of gastric acid.
Participants with history of oesophageal varix (varices)
Participants with history of malignant neoplasm of gastrointestinal tract.
Participants with history of thrombosis or administered with anti-thrombotic drugs.
Participants administered with H2 receptor antagonists, muscarinic receptor antagonists, gastrin receptor antagonist, proton pump inhibitors, prostaglandins or mucosal protective agents prior to study in 1 weeks.
Participants with history of Zollinger-Ellison syndrome
Participants documented with auto-immune disease, uncontrolled hypertension, Diabetes mellitus requiring insulin injections and chronic severe respiratory disease.
History of life threatening cardiovascular and /or neurological event in the past one year.
Participants with history of drug abuse, bleeding disorder.
Participants who cannot give valid consent such as mentally retarded, unconscious participants and psychiatric illness.
Known history of positive screening result for hepatitis B and/or Hepatitis C virus.
History of HIV or any immune deficient conditions.
Participants on corticosteroid, sleep medication, antipsychotic drugs.
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Change in the Amlapitta Symptom Rating Scale score compared to baseline |
30 Days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Enhancing awareness of circadian health and Dosha management through Ayurvedic principles.
Change in the PPDS symptom scale compared to baseline
Change in the EPS symptom scale compared to baseline
Change in the GERD scale compared to baseline
|
30 Days |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
05/11/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
PHASE 1 – OBSERVATIONAL STUDY RESEARCH QUESTION: Is there any association between doshic imbalance and circadian rhythm alteration among night workers having Amlapitta HYPOTHESIS Null Hypothesis [H01]- There is no association between doshic imbalance and circadian rhythm alteration among night workers having Amlapitta. Alternative Hypothesis [HA] – There is association between doshic imbalance and circadian rhythm alteration among night workers having Amlapitta. 4. AIM: To study the association between circadian rhythm alteration and doshic imbalance among night workers having Amlapitta. Primary Objective To correlate serum cortisol levels with circadian rhythm alteration and doshic imbalance as a biomarker of physiological stress. Secondary Objectives - To assess the distribution of chronotypes (morning, intermediate, evening types) among night workers using the Morningness-Eveningness Questionnaire (MEQ).[i]
- To identify the predominant doshic imbalance (Vata, Pitta, Kapha, or their combinations) associated with circadian rhythm disturbances.
- To explore the relationship between the degree of circadian misalignment and the severity of doshic imbalance.
PHASE 2 – CLINICAL STUDY RESEARCH QUESTION: Is there any difference in efficacy of Yavadi Kwatha and Amlapitta Mishran in management of Amlapitta among night workers? HYPOTHESIS: Null Hypothesis [H01]: There is no difference in the efficacy of Yavadi Kwatha and Amlapitta Mishran in managing Amlapitta in night workers. Alternate Hypothesis [HA]: There is a difference in the efficacy of Yavadi Kwatha and Amlapitta Mishran in managing Amlapitta in night workers. AIM: To compare difference in the efficacy of Yavadi Kwatha and Amlapitta Mishran in managing Amlapitta among night workers. OBJECTIVES: Primary Objective: To evaluate efficacy of Yavadi Kwatha and Amlapitta Mishran Suspension in improvement of Amlapitta Symptom Rating Scale from baseline to day 30. Secondary Objectives To evaluate efficacy of Yavadi Kwatha and Amlapitta Mishran Suspension in improvement of Post Prandial Distress Syndrome (PPDS) score from baseline to day 30. To evaluate efficacy of Yavadi Kwatha and Amlapitta Mishran Suspension in improvement of Epigastric Pain Syndrome (EPS) score from baseline to day 30. To assess the safety of Yavadi Kwatha and Amlapitta Mishran Suspension on GERD Scale score from baseline to day 30.
ASSESSMENT CRITERIA Amlapitta Symptom Ratings Scale: Scale of 0-21 | Grades of severity | Score | Characteristics | | Avipaak (Indigestion) | | G0 | 0 | no indigestion | | G1 | 1 | digests normal usual diet in 09 hours | | G2 | 2 | digests normal usual diet in 12 hours | | G3 | 3 | digests normal usual diet in 24 hours or more | | Klama (Tiredness) | | G0 | 0 | no tiredness | | G1 | 1 | feel tired after exertion work | | G2 | 2 | feel tired after normal work | | G3 | 3 | feel tired even after taking rest | | Utklesha (Nausea) | | G0 | 0 | no nausea | | G1 | 1 | Feel nausea after eating some peculiar food | | G2 | 2 | feel nausea after eating all kinds of food | | G3 | 3 | full day nausea, not related to eating | | Tikta amla udgaar (Sour and bitter belching) | | G0 | 0 | no sour and bitter belching | | G1 | 1 | sour and bitter belching after taking spicy food | | G2 | 2 | sour and bitter belching after taking any type of food | | G3 | 3 | sour and bitter belching having no relation with food intake | | Guruta (Feeling of heaviness in the body) | | G0 | 0 | no feeling of heaviness in the body | | G1 | 1 | heaviness after taking more quantity of heavy food | | G2 | 2 | heaviness even after taking light food | | G3 | 3 | heaviness even on empty stomach | | Hrit-Kantha Daha (Burning sensation) | | G0 | 0 | no Burning sensation | | G1 | 1 | burning sensation after intake of spicy food | | G2 | 2 | feeling of burning sensation even after intake of normal food | | G3 | 3 | burning sensation even empty stomach | | Aruchi (Anorexia) | | G0 | 0 | no anorexia | | G1 | 1 | eat food only two times without any snacks in between | | G2 | 2 | eat only once | | G3 | 3 | have no feeling of appetite | | Total score range: 0-21 |
Functional Dyspepsia is divided into Postprandial Distress Syndrome (PPDS) and Epigastric Pain Syndrome (EPS). Criteria for PPDS and EPS will be recorded on a Likert scale to see improvement in the symptoms at the end of treatment. Postprandial Distress Syndrome (PPDS) Diagnostic Criteria score: Bothersome postprandial fullness severe enough to impact on usual activities) – Likert scale of 1 (very mild) to 5 (very severe). Bothersome early satiation severe enough to prevent finishing a regular-size meal) – Likert scale of 1 (very mild) to 5 (very severe). Epigastric Pain Syndrome (EPS) Diagnostic criteria score: Bothersome epigastric pain severe enough to impact on usual activities) - Likert scale of 1 (very mild) to 5 (very severe). Bothersome epigastric burning severe enough to impact on usual activities) - Likert scale of 1 (very mild) to 5 (very severe)
GERD Health Related Quality of Life (GERD HRQL) Questionnaire |